HCPCS Level II · Drugs administered other than oral method
J7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mg
Terminated 09/30/2026
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J7514
J7514 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing mycophenolate mofetil (myhibbin), oral suspension, 100 mg.
It was added to HCPCS effective 01/01/2025, and its current record took effect 10/01/2026.
It was terminated on 09/30/2026 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Mycophenol (myhibbin) 100 mg
- Date added
- 01/01/2025
- Action effective
- 10/01/2026
- Termination date
- 09/30/2026
- BETOS
- O1E
Related J75xx codes
- J7500Azathioprine, oral, 50 mg
- J7501Azathioprine, parenteral, 100 mg
- J7502Cyclosporine, oral, 100 mg
- J7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7507Tacrolimus, immediate release, oral, 1 mg
- J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509Methylprednisolone oral, per 4 mg
- J7510Prednisolone oral, per 5 mg
- J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512Prednisone, immediate release or delayed release, oral, 1 mg
- J7515Cyclosporine, oral, 25 mg
Common questions about J7514
Is HCPCS J7514 still valid?
- No. J7514 was terminated on 09/30/2026.
Does Medicare cover J7514?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.